Valeant Pharmaceuticals International (VRX)

Slide schematic 4/4

callout 2/2 list 1/1 title 1/1

Components 4

primary primary bullet headline

Tools 1

Problem Statement Canvas slide · 70%

The traditional multiple-of-earnings valuation approach: Measures the earnings of the company’s existing asset base; Applies a multiple to earnings that reflects growth potential and risk; Ignores the value

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

Valeant Pharmaceuticals International (VRX) · slide 23